| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/11/2012 | CN102317278A 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2 |
| 01/11/2012 | CN102317276A Pharmaceutical compositions of 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate |
| 01/11/2012 | CN102317273A (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives |
| 01/11/2012 | CN102317270A Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
| 01/11/2012 | CN102317269A Novel amino azaheterocyclic carboxamides |
| 01/11/2012 | CN102317268A 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors |
| 01/11/2012 | CN102317267A Process for the preparation of rosuvastatin salts |
| 01/11/2012 | CN102317266A 6-phenylpyrimidinones as PIM modulators |
| 01/11/2012 | CN102317265A 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |
| 01/11/2012 | CN102317264A 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino}-l-hydroxyethyl) -8-hydroxyquin olin-2 (1h)-one and its use in the treatment of pulmonary diseases |
| 01/11/2012 | CN102317263A Halogen-substituted compounds as pesticides |
| 01/11/2012 | CN102317262A Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors |
| 01/11/2012 | CN102317261A Triple reuptake inhibitors and methods of their use |
| 01/11/2012 | CN102317257A Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 01/11/2012 | CN102316935A Therapeutic regimen comprising peg- interferon, ribavirin and VX-950 for the treatment of hepatitis |
| 01/11/2012 | CN102316932A Methods of treating hair related conditions |
| 01/11/2012 | CN102316931A Alkylamido compounds and uses thereof |
| 01/11/2012 | CN102316906A Chlorhexidine acetate antiseptic cleaning agent |
| 01/11/2012 | CN102316901A Transdermal preparation |
| 01/11/2012 | CN102316900A Aniline derivative having anti-rna viral activity |
| 01/11/2012 | CN102316878A Glycolipid mixture with antiinflammatory acivity obtained from oscillatoria planktothrix |
| 01/11/2012 | CN102316877A Methods of treating a meiotic kinesin-associated disease |
| 01/11/2012 | CN102316876A High dosage doramectin formulation |
| 01/11/2012 | CN102316875A Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabete mellitus, impaired glucose tolerance or hyperglycemia |
| 01/11/2012 | CN102316874A A disintegrating tablet |
| 01/11/2012 | CN102316873A Compounds and methods for enhancing erythropoiesis |
| 01/11/2012 | CN102316872A Bile acid recycling inhibitors for treatment of obesity and diabetes |
| 01/11/2012 | CN102316871A [1,2,4]thiadiazine 1,1-dioxide compounds |
| 01/11/2012 | CN102316870A Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |
| 01/11/2012 | CN102316869A Method of treating cancer |
| 01/11/2012 | CN102316868A Method for treating macular degeneration |
| 01/11/2012 | CN102316866A Skin treatment |
| 01/11/2012 | CN102316865A L-lysine for improving normal cognitive functions |
| 01/11/2012 | CN102316864A Chronotherapeutic pharmaceutical composition |
| 01/11/2012 | CN102316863A Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof |
| 01/11/2012 | CN102316862A Methods for preparing s1p receptor agonists and antagonists |
| 01/11/2012 | CN102316861A Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof |
| 01/11/2012 | CN102316856A Pharmaceutical preparation |
| 01/11/2012 | CN102316854A Solid compositions |
| 01/11/2012 | CN102316853A Device and method for producing pharmaceutically highly refined particles and for coating said particles in microreactors |
| 01/11/2012 | CN102316852A Liposomal citicoline injection |
| 01/11/2012 | CN102316850A A composition for buccal absorption of nicotine for the purpose of smoking cessation |
| 01/11/2012 | CN102316832A Sustainedly drug-releasing hydrogel contact lens, and drug releasing method using sustainedly drug-releasing hydrogel contact lens |
| 01/11/2012 | CN102316738A Amides as kinase inhibitors |
| 01/11/2012 | CN102316737A Compounds for RHO kinase inhibition and for improving learning and memory |
| 01/11/2012 | CN102316735A Small molecule inhibitors of necroptosis |
| 01/11/2012 | CN102316732A Azepino [4, 5-b] indoles and methods of use |
| 01/11/2012 | CN102311482A Aro-peptide and preparation method as well as medicinal combination and application of aro-peptide |
| 01/11/2012 | CN102311481A Methyl toonapubesate A and preparation method as well as application thereof |
| 01/11/2012 | CN102311476A Toonapubesin C and preparation method as well as application thereof |
| 01/11/2012 | CN102311475A New compound separated from Mythic Fungus, preparation method thereof and medicinal purpose thereof |
| 01/11/2012 | CN102311473A Toonapubesic aldehyde and preparation method as well as application thereof |
| 01/11/2012 | CN102311471A Levorotary isovaleryl spiramycin II as well as preparation, preparation method and application thereof |
| 01/11/2012 | CN102311452A Cefixime crystal, preparation method thereof and tablet composition containing same |
| 01/11/2012 | CN102311451A Ticarcillin disodium hydrate and preparation method as well as application thereof |
| 01/11/2012 | CN102311449A Application of gossypol derivative to preparing anti-tumor medicament |
| 01/11/2012 | CN102311448A Thieno-pyrimidone DPP-IV (dipeptidyl peptidase) inhibitor |
| 01/11/2012 | CN102311447A Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor |
| 01/11/2012 | CN102311442A Spirolactam alkaloid compound with anti-tumor activity and preparation method as well as application thereof |
| 01/11/2012 | CN102311439A 1-substituted-3,8-diazabicyclo[3.2.1] octane derivative and preparation method thereof |
| 01/11/2012 | CN102311438A Quinazoline compound |
| 01/11/2012 | CN102311434A Evodiamine compounds, preparation method thereof and application thereof |
| 01/11/2012 | CN102311432A Stable vinpocetine compound and pharmaceutical composition thereof |
| 01/11/2012 | CN102311430A Novel crystalline state of iloperidone and preparation method thereof |
| 01/11/2012 | CN102311425A Anticoccidiosis compound and preparation method as well as application thereof |
| 01/11/2012 | CN102311423A Preparation method and application of novel antibacterial and anticancer compounds |
| 01/11/2012 | CN102311416A Hydroxy substituted flavonoid compound, preparation method and application thereof |
| 01/11/2012 | CN102311407A Preparation method for S(+) toloperisone and pharmaceutical use thereof |
| 01/11/2012 | CN102311401A Cetp inhibitors |
| 01/11/2012 | CN102311399A Triazole alcohol antifungal compounds with nitrogen-containing side chains, preparation method thereof and application thereof |
| 01/11/2012 | CN102311398A Triazole compounds, preparation method thereof, and application thereof in preparing histone deacetylase I inhibitor |
| 01/11/2012 | CN102311396A Pyrazine derivative and preparation method as well as application thereof to pharmacy |
| 01/11/2012 | CN102311395A Quinazoline ring substituted diphenylurea derivative and its purpose |
| 01/11/2012 | CN102311389A Azoaryl substituted pyrazole derivative and synthesis as well as anti-cancer application thereof |
| 01/11/2012 | CN102311387A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 01/11/2012 | CN102311385A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/11/2012 | CN102311383A Phenazopyridine hydrochloride crystal compound and pharmaceutical composition tablet thereof |
| 01/11/2012 | CN102311382A Novel crystalline state of roflumilast and preparation method thereof |
| 01/11/2012 | CN102311380A Piperidyl-4-carboxyl amide derivative and preparation method as well as application thereof |
| 01/11/2012 | CN102311378A Fused pyrazole derivatives and uses thereof in methods of treatment of metabolic-related disorders |
| 01/11/2012 | CN102309767A Soluble osthole clathrate, dispersing tablet and preparation method thereof |
| 01/11/2012 | CN102309766A Method for improving water solubility of xanthohumol |
| 01/11/2012 | CN102309763A Medicinal composition and preparation method thereof |
| 01/11/2012 | CN102309761A Uncharged amphiphilic chitosan nano drug carrier and preparation method and application thereof |
| 01/11/2012 | CN102309760A Cationic amphiphilic chitosan nano drug carrier and preparation method and application thereof |
| 01/11/2012 | CN102309756A Compound medicament containing phosphodiesterase 4 inhibitor and glucocorticoid and used for treating dermatosis |
| 01/11/2012 | CN102309752A Protein related to brain ageing and Alzheimer's disease and application thereof |
| 01/11/2012 | CN102309751A Superoxide dismutase (SOD) composite capsule and preparation method thereof |
| 01/11/2012 | CN102309750A Special conditioning and nourishing film for use at genital of woman |
| 01/11/2012 | CN102309749A Nutritional ointment for treating foot and hand cracks |
| 01/11/2012 | CN102309724A Pharmaceutical composition for treating breast diseases and preparation method thereof |
| 01/11/2012 | CN102309722A Medicinal liquor for treating injury and preparation method of same |
| 01/11/2012 | CN102309718A Deposition-eliminating congestion-relieving paste |
| 01/11/2012 | CN102309717A Traditional Chinese medicine decoction for treating toxic hepatitis |
| 01/11/2012 | CN102309689A Gastrodia elata chewing gum agent, preparation method and detection method thereof |
| 01/11/2012 | CN102309672A Traditional Chinese medicinal patche for controlling snoring |
| 01/11/2012 | CN102309668A Medicament for treating anemopyretic toothache and preparation method thereof |
| 01/11/2012 | CN102309667A Ointment for treating scald and preparation method thereof |
| 01/11/2012 | CN102309650A Traditional Chinese medicinal composition for regulating menstruation |
| 01/11/2012 | CN102309646A Medicament for treating fracture and method for preparation and application |